http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109355382-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5689d3da9cc47b0bc0059368bfe9b1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2018-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3196a4c29514160852bf7db954efcf53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad318c9de30e997ff195928049e508d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342ac50ef3f4dc468c59579ea0da02c0 |
| publicationDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109355382-A |
| titleOfInvention | Oligonucleotides, methods and kits for detecting PRCC-TFE3 fusion gene in samples |
| abstract | The invention discloses oligonucleotides, methods and kits for detecting PRCC-TFE3 fusion genes in samples, which include upstream and downstream primers and probes for type 1 PRCC-TFE3, and upstream and downstream primers for type 2 PRCC-TFE3 and probes, upstream and downstream primers and probes for type 3 PRCC-TFE3, upstream and downstream primers and probes for type 4 PRCC-TFE3, and upstream and downstream primers and probes for β-actin internal reference gene. The invention can quickly detect whether the PRCC-TFE3 fusion gene exists in the sample and the amount of its expression. The detection results completed by the present invention are accurate and sensitive, and can assist in formulating individualized treatment plans for patients with human Xp11.2 translocation/TFE3 fusion gene-related renal cancer. |
| priorityDate | 2018-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.